解决帕金森病患者的并发症:专家小组的考虑
Camille Carroll1,2, Carl E Clarke3, Donald Grosset4
1Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Journal of Parkinson's disease
|January 13, 2024
概括
解决帕金森病 (PD) 中常见的并发症对于个性化护理至关重要. 专注于骨健康,心血管风险,抗胆固醇负担和睡眠质量可以显著改善患者的结果.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 临床药房 临床药房
背景情况:
- 目前英国关于帕金森病 (PD) 治疗启动和治疗选择的指南强调个性化的患者护理.
- 国家卫生和护理卓越研究所 (NICE) 的指南建议进行全面的讨论,涵盖临床情况,生活方式,偏好,目标和治疗风险/益处.
- 个性化管理显著提高了PD患者的治疗结果和生活质量.
研究的目的:
- 为临床医生提供关于在患有帕金森病 (PwP) 的人群中管理常见的,经常被忽视的并发症的实际指导.
- 通过对PD患者共存疾病的标准化管理,确定改善临床护理的关键领域.
主要方法:
- 通过临床经验和现有文献进行的多学科专家圆桌讨论.
- 这次会议是由Bial Pharma UK Ltd.组织和资助的.
- 专家们确定并优先考虑了改善PD管理的四个核心领域.
主要成果:
- 确定了四个核心共患病领域:骨健康,心血管风险,抗胆固醇负担和睡眠质量.
- 预计这些领域的管理标准化将改善普华永道的治疗结果.
- 专注于这些领域有助于个性化PD治疗方案,并提高患者的整体幸福感.
结论:
- 解决PD中的特定并发病症可以显著促进个性化患者护理.
- 这些指导因素旨在帮助从业人员优化帕金森病患者的管理.
- 改善骨健康,心脏风险,睡眠和抗胆固醇负担的管理是改善患者结果的关键.
相关概念视频
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
01:20COPD: Pathogenesis and Clinical Features
275
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
275